A study of tropomyosin's role in cardiac function and disease using thin-filament reconstituted myocardium

被引:44
作者
Bai, Fan [1 ,2 ]
Wang, Li [1 ,2 ]
Kawai, Masataka [1 ,2 ]
机构
[1] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
关键词
HCM; DCM; LVNC; Hypertrophic cardiomyopathy; Dilated cardiomyopathy; Left ventricular noncompaction; Cross-bridge kinetics; Elementary steps; Sinusoidal analysis; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CROSS-BRIDGE KINETICS; LEFT-VENTRICULAR NONCOMPACTION; PROTEIN-C PHOSPHORYLATION; MYOSIN HEAVY-CHAIN; ALPHA-TROPOMYOSIN; DILATED CARDIOMYOPATHY; ISOMETRIC TENSION; CA2+ SENSITIVITY; FORCE GENERATION;
D O I
10.1007/s10974-013-9343-z
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Tropomyosin (Tm) is the key regulatory component of the thin-filament and plays a central role in the cardiac muscle's cooperative activation mechanism. Many mutations of cardiac Tm are related to hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and left ventricular noncompaction (LVNC). Using the thin-filament extraction/reconstitution technique, we are able to incorporate various Tm mutants and protein isoforms into a muscle fiber environment to study their roles in Ca2+ regulation, cross-bridge kinetics, and force generation. The thin-filament reconstitution technique poses several advantages compared to other in vitro and in vivo methods: (1) Tm mutants and isoforms are placed into the real muscle fiber environment to exhibit their effect on a level much higher than simple protein complexes; (2) only the primary and immediate effects of Tm mutants are studied in the thin-filament reconstituted myocardium; (3) lethal mutants of Tm can be studied without causing a problem; and (4) inexpensive. In transgenic models, various secondary effects (myocyte disarray, ECM fibrosis, altered protein phosphorylation levels, etc.) also affect the performance of the myocardium, making it very difficult to isolate the primary effect of the mutation. Our studies on Tm have demonstrated that: (1) Tm positively enhances the hydrophobic interaction between actin and myosin in the "closed state", which in turn enhances the isometric tension; (2) Tm's seven periodical repeats carry distinct functions, with the 3rd period being essential for the tension enhancement; (3) Tm mutants lead to HCM by impairing the relaxation on one hand, and lead to DCM by over inhibition of the AM interaction on the other hand. Ca2+ sensitivity is affected by inorganic phosphate, ionic strength, and phosphorylation of constituent proteins; hence it may not be the primary cause of the pathogenesis. Here, we review our current knowledge regarding Tm's effect on the actomyosin interaction and the early molecular pathogenesis of Tm mutation related to HCM, DCM, and LVNC.
引用
收藏
页码:295 / 310
页数:16
相关论文
共 146 条
[1]   Diagnostic Yield, Interpretation, and Clinical Utility of Mutation Screening of Sarcomere Encoding Genes in Danish Hypertrophic Cardiomyopathy Patients and Relatives [J].
Andersen, Paal Skytt ;
Havndrup, Ole ;
Hougs, Lotte ;
Sorensen, Karina M. ;
Jensen, Morten ;
Larsen, Lars Allan ;
Hedley, Paula ;
Thomsen, Alex Rojas Bie ;
Moolman-Smook, Johanna ;
Christiansen, Michael ;
Bundgaard, Henning .
HUMAN MUTATION, 2009, 30 (03) :363-370
[2]   Analysis of the Molecular Pathogenesis of Cardiomyopathy-Causing cTnT Mutants 179N, ΔE96, and ΔK210 [J].
Bai, Fan ;
Caster, Hannah M. ;
Pinto, Jose R. ;
Kawai, Masataka .
BIOPHYSICAL JOURNAL, 2013, 104 (09) :1979-1988
[3]   DCM-Related Tropomyosin Mutants E40K/E54K Over-Inhibit the Actomyosin Interaction and Lead to a Decrease in the Number of Cycling Cross-Bridges [J].
Bai, Fan ;
Groth, Heather L. ;
Kawai, Masataka .
PLOS ONE, 2012, 7 (10)
[4]   Enhanced Active Cross-Bridges during Diastole: Molecular Pathogenesis of Tropomyosin's HCM Mutations [J].
Bai, Fan ;
Weis, Adam ;
Takeda, Aya K. ;
Chase, P. Bryant ;
Kawai, Masataka .
BIOPHYSICAL JOURNAL, 2011, 100 (04) :1014-1023
[5]   Hypertrophic cardiomyopathy [J].
John T. Barron .
Current Treatment Options in Cardiovascular Medicine, 1999, 1 (3) :277-282
[6]   Regulation of actin-myosin interaction by conserved periodic sites of tropomyosin [J].
Barua, Bipasha ;
Winkelmann, Donald A. ;
White, Howard D. ;
Hitchcock-DeGregori, Sarah E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (45) :18425-18430
[7]   Evolutionarily conserved surface residues constitute actin binding sites of tropomyosin [J].
Barua, Bipasha ;
Pamula, Melissa C. ;
Hitchcock-DeGregori, Sarah E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (25) :10150-10155
[8]   Structure of the Rigor Actin-Tropomyosin-Myosin Complex [J].
Behrmann, Elmar ;
Mueller, Mirco ;
Penczek, Pawel A. ;
Mannherz, Hans Georg ;
Manstein, Dietmar J. ;
Raunser, Stefan .
CELL, 2012, 150 (02) :327-338
[9]   Molecular distinction between physiological and pathological cardiac hypertrophy: Experimental findings and therapeutic strategies [J].
Bernardo, Bianca C. ;
Weeks, Kate L. ;
Pretorius, Lynette ;
McMullen, Julie R. .
PHARMACOLOGY & THERAPEUTICS, 2010, 128 (01) :191-227
[10]   A simple method for measuring the relative force exerted by myosin on actin filaments in the in vitro motility assay:: evidence that tropomyosin and troponin increase force in single thin filaments [J].
Bing, W ;
Knott, A ;
Marston, SB .
BIOCHEMICAL JOURNAL, 2000, 350 :693-699